A Texas lawmaker introduced a bill on Wednesday that would require the state to study the therapeutic potential of psilocybin, MDMA and ketamine in the treatment of certain mental health conditions.
The legislation from Rep. Alex Dominguez (D) would mandate that the Department of State Health Services conduct the study in collaboration with the Texas Medical Board and report on its findings by December 1, 2022.
Researchers should “evaluate and determine whether alternative therapies are effective in treating the mental health and other medical conditions” such as depression, anxiety, post-traumatic stress disorder, bipolar disorder, chronic pain and migraines, the text of the bill, HB 1802, states.
The study should also “compare the efficacy of the alternative therapies with the efficacy of treatments currently used for the mental health and other medical conditions,” it continues.
Marijuana Moment is already tracking more than 600 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
The bill comes as the debate about drug policy reform is increasingly extending beyond marijuana and is just the latest example of state lawmakers taking psychedelics and other alternative therapies more seriously amid a national movement to decriminalize entheogenic substances that has played out in cities across the country in recent years.
In Oregon, voters approved historic initiatives to legalize psilocybin for therapeutic purposes and decriminalize drugs more broadly in November. Lawmakers in California, Connecticut, Florida, Hawaii, New York, Virginia and Washington State are also considering psychedelics and drug policy reform bills for the 2021 session.
A GOP legislator in Iowa also introduced legislation that would decriminalize psilocybin this week.
But getting psychedelics reform passed in Texas may prove challenging given the state legislature’s resistance to marijuana legalization over the years. That said, there are some signals that lawmakers are feeling more open to the debate this session.
More than a dozen pieces of marijuana legislation were prefiled for 2021, and that includes proposals that would legalize cannabis for adult use, legalize high-THC cannabis for medical use and decriminalize small-scale possession of marijuana.
House Speaker Dade Phelan (R) said last month that the chamber “will look at [reform measures] again and review those again, and some will get traction, some will not.”
Lt. Gov. Dan Patrick (R), who presides over the state Senate, suggested that he may be inclined to entertain debate over further medical cannabis reform, but he’s made clear that he’s opposed to broader legalization.
“We’re always listening on the health issues, but we’re not going to turn this into California,” he said, “where anybody can get a slip from the doctor and go down to some retail store and say, ‘You know, I got a headache today so I need marijuana,’ because that’s just a veil for legalizing it for recreational use.”
Read the text of the Texas psilocybin and MDMA research bill below:
Photo courtesy of Wikimedia/Mushroom Observer.